CA2+, GAP JUNCTIONS & COMMUNICATION IN ALVEOLAR II CELLS
CA2+, GAP JUNCTIONS & COMMUNICATION IN ALVEOLAR II CELLS
批准号:
6085049
负责人:
Scott Boitano
金额:
$13.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-03-01 至 2002-02-28
中文摘要
呼吸系统疾病每年导致相当数量的全科医生(约25%)和医院(约30%)就诊。这些疾病中的许多都源于肺泡II型细胞功能失调的细胞生理。肺泡II型细胞是构成肺内膜的上皮细胞。除其他外,这些细胞在肺内提供关键的分泌物,防止肺崩溃,并提供适当的水环境,允许适当的氧气交换。同样重要的是,肺泡细胞在损伤或损伤后细胞层的一般维持中起着至关重要的作用。严重的哮喘、慢性支气管炎、支气管扩张、感染或损伤后,肺泡II细胞功能障碍可对肺生理产生严重影响(例如氧气转移减少、液体界面改变或细胞类型在肺表面错位,从而进一步加剧疾病状态)。在任何给定的时间,都有数万到数十万的肺泡II细胞共同工作,以维持肺内环境的稳定。然而,关于肺泡细胞协同工作以维持正常肺功能的细胞机制知之甚少。这项建议的目的是利用先进的显微镜技术,使我们能够监测细胞之间的通信路径,并发现肺泡细胞如何协调其功能。我们必须了解导致沟通和协调的组织和器官结果的基本细胞过程。利用肺泡细胞间通讯的模型系统,可以加快制定和测试肺泡细胞生理学功能障碍的新医疗方法,这种细胞生理学是肺部疾病、损伤和损伤后特定呼吸道状况的基础。
英文摘要
Respiratory ailments are responsible for a significant number of general practitioner (approximately 25 percent) and hospital (approximately 30 percent) visits each year. Many of these ailments are rooting in the dysfunctional cellular physiology of alveolar type II cells. Alveolar type II cells are epithelial cells that contribute to the lining of the lung. Among other things, these cells provide critical secretions in the lung that keep the lung from collapsing and provide for a proper aqueous environment that allows for proper oxygen exchange. Just as importantly, alveolar cells are crucial in general maintenance of the cellular layer following insult or injury. Dysfunction of alveolar II cells, as seen after severe cases of asthma, chronic bronchitis, bronchiectasis, infection or injury, can have serious effects on lung physiology, (e.g. reduced O2 transfer, altered liquid interface, or misplacement of cell types at the lung surface that further exasperate the diseased state). At any given time, there are tens to hundreds of thousands of alveolar II cells working together to maintain lung homeostasis. However, there is little known concerning the cellular mechanisms that allow for alveolar cells work together for normal lung function. It is the purpose of this proposal to utilize advanced microscopy techniques that allows us to monitor communication pathways between cells and discover how alveolar cells coordinate their function. It is essential that we understand the basic cellular processes that lead to communicated and coordinated tissue and organ outcomes. With a model system for alveolar intercellular communication could expedite the formulating and testing of new medical treatments for dysfunctional alveolar cell physiology that underlies specific airway conditions following disease, insult and injury in the lung.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Laminin-332 alters connexin profile, dye coupling and intercellular Ca2+ waves in ciliated tracheal epithelial cells.
层粘连蛋白332在纤毛气管上皮细胞中改变连接蛋白的谱,染料偶联和细胞间Ca2+波。
DOI:
10.1186/1465-9921-7-105
发表时间:
2006-08-02
期刊:
Respiratory research
影响因子:
5.8
作者:
[]
通讯作者:
Development of small molecule Protease-activated-receptor-2 antagonists as oral asthma therapeutics
-
批准号:10766584
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2023
-
负责人:Scott Boitano
-
依托单位:
Development of SP-A Derived Peptidomimetics for the Treatment of Asthma - Phase II
-
批准号:10551972
-
项目类别:
-
资助金额:$195.56万
-
财政年份:2022
-
负责人:Scott Boitano
-
依托单位:
Development of SP-A Derived Peptidomimetics for the Treatment of Asthma - Phase II
-
批准号:10708853
-
项目类别:
-
资助金额:$147.82万
-
财政年份:2022
-
负责人:Scott Boitano
-
依托单位:
Development of Small Molecule Antagonists of PAR-2 for treatment of asthma
-
批准号:10326155
-
项目类别:
-
资助金额:$28.34万
-
财政年份:2021
-
负责人:Scott Boitano
-
依托单位:
Development of surfactant protein A-derived peptidomimetics for the treatment of asthma
-
批准号:10019073
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2020
-
负责人:Scott Boitano
-
依托单位:
Development of PAR2 Antagonists for Control of Asthma
-
批准号:9592081
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2018
-
负责人:Scott Boitano
-
依托单位:
Protease Activated Receptor Type 2 Targeting for Migraine Pain
-
批准号:10161867
-
项目类别:
-
资助金额:$48.11万
-
财政年份:2017
-
负责人:Scott Boitano
-
依托单位:
Protease Activated Receptor Type 2 Targeting for Migraine Pain
-
批准号:9927698
-
项目类别:
-
资助金额:$48.11万
-
财政年份:2017
-
负责人:Scott Boitano
-
依托单位:
Protease Activated Receptor Type 2 Targeting for Migraine Pain
-
批准号:9397091
-
项目类别:
-
资助金额:$49.43万
-
财政年份:2017
-
负责人:Scott Boitano
-
依托单位:
Protease Activated Receptor Type 2 Targeting for Migraine Pain
-
批准号:9293876
-
项目类别:
-
资助金额:$43.92万
-
财政年份:2016
-
负责人:Scott Boitano
-
依托单位:
PAR2 targeted drug discovery for the treatment of pain
-
批准号:8543773
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2011
-
负责人:Scott Boitano
-
依托单位:
PAR2 targeted drug discovery for the treatment of pain
-
批准号:8320115
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2011
-
负责人:Scott Boitano
-
依托单位:
PAR2 targeted drug discovery for the treatment of pain
-
批准号:8723906
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2011
-
负责人:Scott Boitano
-
依托单位:
PAR2 targeted drug discovery for the treatment of pain
-
批准号:8237519
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2011
-
负责人:Scott Boitano
-
依托单位:
International Gap Junction Conference 2009
-
批准号:7750265
-
项目类别:
-
资助金额:$1.73万
-
财政年份:2009
-
负责人:Scott Boitano
-
依托单位:
MODELING AIRWAY RESPONSE TO BORDETELLA SP INFECTION
-
批准号:6499041
-
项目类别:
-
资助金额:$17.3万
-
财政年份:2001
-
负责人:Scott Boitano
-
依托单位:
MODELING AIRWAY RESPONSE TO BORDETELLA SP INFECTION
-
批准号:6629059
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2001
-
负责人:Scott Boitano
-
依托单位:
MODELING AIRWAY RESPONSE TO BORDETELLA SP INFECTION
-
批准号:6262696
-
项目类别:
-
资助金额:$17.22万
-
财政年份:2001
-
负责人:Scott Boitano
-
依托单位:
海外基金